MedTrace Logo

The Influence of Amitriptyline on Learning in a Visual Discrimination Task

NCT01566825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2012-03-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether 75 mg amitriptyline affect the sleep dependent consolidation of procedural memory (visual discrimination task, Karni-Sagi-paradigm).

Conditions

  • Healthy Subjects

Interventions

DRUG

Amitriptyline

amitriptyline 25 mg at 9:30 pm, day 10, and 50 mg at 1:30 am, day 11

DRUG

Placebo

placebo(white 8 mm Lichtenstein®) at 9:30 pm, day 10, and at 1:30 am, day 11

Sponsors & Collaborators

  • Dieter Kunz, MD

    lead OTHER

Principal Investigators

  • Dieter Kunz, MD · Charite University, Berlin, Germany

  • Dieter Kunz, MD · Charite University, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01566825 on ClinicalTrials.gov